You are here: Industry Insights > cancer

News List

Predictions of early responses in paediatric acute lymphoblastic leukaemia europeanpharmaceuticalreview
December 17, 2018
Researchers have identified markers of pediatric acute lymphoblastic leukaemia to predict early relapses by testing levels of nucleotide excision repair…
Most pharma firms doing little R&D for poorer patients pharmaphorum
December 17, 2018
A ranking of pharma companies developing new medicines for low- and middle-income countries has revealed that just five companies are responsible for almost two-thirds of projects.....
Apixaban Prevents VTE in Cancer Patients Initiating Chemotherapy drugs
December 17, 2018
Among patients with cancer starting chemotherapy who are at intermediate-to-high risk, rates of venous thromboembolism are significantly lower for thromboprophylaxis with apixaban versus placebo.....
Prestige BioPharma Partners with Cipla Ltd to Market Key Cancer Biosimilar b3cnewswire
December 17, 2018
Prestige BioPharma (“Prestige”) announced today that it has reached a licensing agreement with Cipla Limited (“Cipla”) for its trastuzumab biosimilar (HD201) under which......
AstraZeneca and Cancer Research UK open functional genomics centre pharmaceutical
December 13, 2018
AstraZeneca has partnered with Cancer Research UK to open a functional genomics centre of excellence focused on accelerating the discovery and development of new oncology medicines.
Litmus and NIH study use of wearables in cancer R&D pharmaphorum
December 13, 2018
Health data firm Litmus Health has been awarded a contract with the National Cancer Institute of the US National Institutes of Health, to use “real-world” digital data to improve drug development.
Sprayable gel with CD47 blockers could be the future of drug delivery for cancer europeanpharmaceuticalreview
December 13, 2018
A sprayable gel containing calcium carbonate nanoparticles with antibodies targeted to block CD47, could be the future of drug delivery for cancer…
Rural patients less likely to survive cancer, study finds pharmatimes
December 13, 2018
The global review, by researchers at the University of Aberdeen, examined 39 studies from developed countries and found that people living in rural locations were 5% less likely to survive cancer.
Amgen contributes $2 million to groundbreaking program providing cancer patients of all backgrounds access to U.S. clinical trials worldpharmanews
December 12, 2018
Amgen and the Lazarex Cancer Foundation have teamed up to support more equitable access to clinical trials for cancer patients in the U.S.
Bristol-Myers and Vedanta to study combination therapy for cancer pharmaceutical-technology
December 12, 2018
Bristol-Myers Squibb has partnered with PureTech Health subsidiary Vedanta Biosciences to study its Opdivo in combination with VE800 drug candidate for the treatment of advanced or metastatic cancers.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 88 89 Next page